EUVIMEDEUVIMED entdecken
Scoping ReviewLeitlinie

Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline

Mellar P Davis, Andrew Davies, Mary Lynn McPherson, Akhila Reddy, Judith A Paice, Eric Roeland, Declan Walsh, Sebastiano Mercadante, Amy Case, Robert Arnold, Eriko Satomi, Gregory Crawford und 2 weitere

Supportive Care in Cancer · 2024-08 · 32 (8)

DOI: 10.1007/s00520-024-08710-0 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Supportive Care in Cancer, online erschienen am 24.07.2024. Verfasst von Mellar P Davis und 13 weiteren Autor:innen. Beteiligte Einrichtung: Geisinger Medical Center, Danville, PA, 17821, USA. mdavis2@geisinger.edu. Hauptthemen laut MEDLINE: Analgesics, Opioid, Cancer Pain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Clinicians regularly prescribe opioids to manage acute and chronic cancer pain, frequently to address acute postoperative pain, and occasionally to manage chronic non-cancer pain. Clinical efficacy may be suboptimal in some patients due to side effects and/or poor response, and opioid rotation/switching (conversions) is frequently necessary. Despite the widespread practice, opioid conversion ratios are inconsistent between clinicians, practices, and countries. Therefore, we performed a scoping systematic review of opioid conversion studies to inform an international eDelphi guideline. METHODS: To ensure a comprehensive review, we conducted a systematic search across multiple databases (OVID Medline, PsycINFO, Embase, EBM-Cochrane Database of Systematic Reviews and Registered Trials, LILACS, IMEMR, AIM, WPRIM) using studies published up to June 2022. Additionally, we performed hand and Google Scholar searches to verify the completeness of our findings. Our inclusion criteria encompassed randomized and non-randomized studies with no age limit, with only a few pediatric studies identified. We included studies on cancer, non-cancer, acute, and chronic pain. The level and grade of evidence were determined based on the Multinational Supportive Care in Cancer (MASCC) criteria. RESULTS: Our search yielded 21,118 abstracts, including 140 randomized (RCT) and 68 non-randomized (NRCT) clinical trials. We compared these results with recently published conversion ratios. Modest correlations were noted between published reviews and the present scoping systematic review. CONCLUSION: The present scoping systematic review found low-quality evidence to support an opioid conversion guideline. We will use these data, including conversion ratios and type and route of administration, to inform an eDelphi guideline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidCancer PainHumansAcute PainChronic PainDose-Response Relationship, DrugPractice Guidelines as Topic

Stichwörter der Autor:innen

ConversionOpioidPainRatioReviewRotationSwitch

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Geisinger Medical Center, Danville, PA, 17821, USA. mdavis2@geisinger.edu.
  • Trinity College Dublin, Dublin, Ireland.
  • University of Maryland, Baltimore, ML, USA.
  • Palliative Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Oregon Health and Science University, Knight Cancer Institute, Portland, OR, USA.

Zitieren

APA

Davis, M. P., Davies, A., McPherson, M. L., Reddy, A., Paice, J. A., Roeland, E., Walsh, D., Mercadante, S., Case, A., Arnold, R., Satomi, E., Crawford, G., Bruera, E., & Ripamonti, C. (2024). Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline. Supportive Care in Cancer, 32(8). https://doi.org/10.1007/s00520-024-08710-0

Vancouver

Davis MP, Davies A, McPherson ML, Reddy A, Paice JA, Roeland E, et al. Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline. Supportive Care in Cancer. 2024;32(8). doi:10.1007/s00520-024-08710-0

BibTeX
@article{Davis2024,
  author = {Davis, Mellar P and Davies, Andrew and McPherson, Mary Lynn and Reddy, Akhila and Paice, Judith A and Roeland, Eric and Walsh, Declan and Mercadante, Sebastiano and Case, Amy and Arnold, Robert and Satomi, Eriko and Crawford, Gregory and Bruera, Eduardo and Ripamonti, Carla},
  title = {Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline},
  journal = {Supportive Care in Cancer},
  year = {2024},
  volume = {32},
  number = {8},
  doi = {10.1007/s00520-024-08710-0}
}
Kostenlos starten →